PCA
MXCT icon

Pallas Capital Advisors’s MaxCyte MXCT Stock Holding History

Pallas Capital Advisors’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2K Buy
+15,629
New +$15.6K ﹤0.01% 1014

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Pallas Capital Advisors's MXCT Position: Q2 2026 in Review

Pallas Capital Advisors opened a new position in MaxCyte (MXCT) in Q2 2026: 15,629 shares worth $19.2K. The stake represents ﹤0.01% of the portfolio and ranks #1014 among its holdings.

123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Pallas Capital Advisors held 15,629 shares of MaxCyte worth $19.2K as of Q2 2026.
  • MaxCyte was a new Pallas Capital Advisors position in Q2 2026.
  • MaxCyte made up ﹤0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #1014 holding.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.